CSPG4 and ovarian cancer: Regarding further steps towards a potential clinical translation of targeting decitabine-upregulated CSPG4 on ovarian cancer cells using CSPG4-specific CAR-T cells, our data gathered from the SKOV-3 model provide several cues for further in vivo testing.